•
Jun 30, 2019

Corcept Therapeutics Q2 2019 Earnings Report

Total Revenue
$72.3M
Previous year: $62.3M
+16.0%
EPS
$0.25
Previous year: $0.2
+25.0%
Gross Profit
$70.9M
Previous year: $61.2M
+15.9%
Cash and Equivalents
$58.1M
Previous year: $31.2M
+86.6%
Free Cash Flow
$25.1M
Previous year: $15.1M
+66.0%
Total Assets
$329M
Previous year: $274M
+19.8%

Corcept Therapeutics

Corcept Therapeutics